Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 11 12 13 14 presentations: 1 to 25 of 346
Meet the Professor: Tips for Clinicians for Genetic Evaluations of Adrenal Disorders
Lauren Fishbein, MD, PhD
University of Colorado School of Medicine, Aurora, CO, USA
from Clinical Endocrinology Update 2021 on September 11, 2021 11:00 AM-11:45 AM
Meet the Professor: Management of Adrenal Tumors in Pregnancy
William F. Young Jr., MD, MSc
Mayo Clinic, Rochester, MN, USA
from Clinical Endocrinology Update 2021 on September 11, 2021 12:00 PM-12:45 PM
Master Clinician: Chromaffin Tumors Perspectives
Lauren Fishbein, MD, PhD
University of Colorado School of Medicine, Aurora, CO, USA
Anand Vaidya, MD, MMSc
Brigham and Women's Hospital, Boston, MA, USA
William F. Young Jr., MD, MSc
Mayo Clinic, Rochester, MN, USA
from Clinical Endocrinology Update 2021 on September 11, 2021 1:00 PM-1:45 PM
Utility of Adrenal Androgens in Clinical Practice
Adina F. Turcu, MD, MS
University of Michigan, Ann Arbor, MI, USA
from Clinical Endocrinology Update 2021 on September 11, 2021 1:00 PM-1:45 PM
Primary Aldosteronism: Once a Zebra, Now a Horse
Anand Vaidya, MD, MMSc
Brigham and Women's Hospital, Boston, MA, USA
from Clinical Endocrinology Update 2021 on September 11, 2021 2:00 PM-2:45 PM
Adrenal Board Review
Tobias Else, MD
University of Michigan, Ann Arbor, Michigan, USA
from Endocrine Board Review 2021 on August 18, 2021 12:00 PM-1:00 PM
Adrenal Board Review Q&A
Tobias Else, MD
University of Michigan, Ann Arbor, Michigan, USA
from Endocrine Board Review 2021 on August 18, 2021 12:00 PM-1:00 PM
Glucocorticoid Signaling in the Fetal and Neonatal Brain
Donald DeFranco, PhD
University of Pittsburgh School of Medicine, Pittsburgh, PA
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Tale of Two Steroids: DHEA and DHEAS
Margaret Zacharin, DMedSci, FRACP
Royal Children's Hospital, Parkville, Australia
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Novel Therapeutic Approaches in the Management of Adrenal Insufficiency
Ashwini Mallappa, MD, MHSc
National Institutes of Health, Bethesda, MD
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Biochemical Twists in the Evaluation of a Patient With Pheochromocytoma
Karel Pacak, MD, PhD, DSc
National Institutes of Health, Bethesda, MD
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
New Challenges in Nuclear Imaging and Treatment of Pheochromocytoma: Too Many Members on Board?
Henri Timmers, MD, PhD
Radboud University Medical Centre, Nijmegen, Netherlands
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
The Achilles’ Heel in Genetic Testing of Pheochromocytoma
Mercedes Robledo, PhD
Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Pituitary Gene Mutations and Cushing Disease
Gunter Stalla, MD
Medicover Neuroendocrinology, University of Munich, Munich, Germany
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Adrenal Somatic Gene Mutations Causing Cortisol Excess
Guido Di Dalmazi, MD
University of Bologna, Bologna, Italy
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Inherited Gene Mutations Causing Primary Macronodular Adrenal Hyperplasia in Familial Cushing’s Syndrome
Maria Fragoso, MD, PhD
Hospital Das Clinicas, University of Sao Paulo, Sao Paulo,, Brazil
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Mild Cushing’s Syndrome: Does It Matter?
Danae Delivanis, MD, PhD
Private Practice, Patras, Greece
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Treatment of Bilateral Adrenal Macronodular Hyperplasia
Jerome Bertherat, MD, PhD
Hopital Cochin, Paris, France
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Focus on Cortisol Excess in Primary Aldosteronism
Adina Turcu, MD, MS
University of Michigan Medical School, Ann Arbor, MI
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
One Size Doesn't Fit All: How Direct and Indirect Mineralocorticoid Actions Control Distal Nephron Sodium Transport
David Ellison, MD
Oregon Health and Science University, Portland, OR
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Glucocorticoid Metabolism in Salt-Induced Hypertension
Matthew Bailey, PhD, FRSB
The University of Edinburgh, Edinburgh, United Kingdom
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Mechanisms of Fructose-Mediated Hypertension: Sodium, RAS and Sympathetic Regulation
Noreen Rossi, MD
Wayne State University, Detroit, MI
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Chair
Maria-Christina Zennaro, MD, PhD
Inserm, Paris, France
Chair
Adina Turcu, MD
University of Michigan Medical School, Ann Arbor, MI
Welcome and Introductions
Aldosterone and Cardiometabolic Disease in African Americans
Joshua Joseph, MD
Ohio State University College of Medicine, Columbus, OH
Live Moderated Q&A
Genetic Advances in Familial and Sporadic Primary Aldosteronism and Their Potential Clinical Implications
Isabelle Bourdeau, MD
Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada
Live Moderated Q&A
New Mechanisms in the Pathophysiology of Primary Aldosteronism
Tracy Williams, PhD
University of Turin, Torino, Italy
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 20, 2021 12:30 PM-2:00 PM
Meet the Professor
David Torpy, MBBS, PhD, FRACP
Royal Adelaide Hospital, Adelaide, Australia
from ENDO 2021 on March 20, 2021 2:00 PM-2:30 PM
Chair
Katja Kiseljak-Vassiliades, DO
University of Colorado Denver, Aurora, CO
Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
Massimo Terzolo, MD
University of Turin San Luigi Hospital, Orbassano, Italy
Audience Q&A
Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
Yasir Elhassan, MD
University of Birmingham, Birmingham, United Kingdom
Audience Q&A
Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL): Results From a Pivotal Phase 2 Clinical Trial
Camilo Jimenez, MD
UT MD Anderson Cancer Center, Houston, TX
Audience Q&A
Mortality and Specific Causes of Death in Endogenous Cushing’s Syndrome: A Systematic Review, Meta-Analysis and Meta-Regression
Padiporn Limumpornpetch, Endocrinologist
University of Leeds, Leeds, United Kingdom
Audience Q&A
from ENDO 2021 on March 20, 2021 2:15 PM-3:15 PM
<< first | < prev page: of 14 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 11 12 13 14 presentations: 1 to 25 of 346